Biocartis Group N.V. | |
Stock Exchange | Euronext Brussels |
EPS |
EUR0.94 |
Market Cap |
EUR603.29 M |
Shares Outstanding |
56.38 M |
Public Float |
40.78 M |
Address |
Generaal de Wittelaan 11 B3 Mechelen VL 2800 Belgium |
Employees | - |
Website | http://www.biocartis.com |
Updated | 07/08/2019 |
Biocartis Group NV is a commercial stage molecular diagnostics company, which engaegs in the provision of diagnostic solutions. It operates through MDx Idylla™ platform, an automated sample-to-result, real-time polymerase chain reaction system that offers molecular information from virtually any biological sample. The company was founded by Renaud Philippe, Nader Donzel, and Rudi Pauwels in July 2007 and is headquartered in Mechelen, Belgium. |